Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Theratechnologies Inc. - Common Shares (NQ:THTX)

3.390 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Theratechnologies Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Theratechnologies Draws Down on US$20 Million Second Tranche Under its Term Loan Facility With Affiliates of Marathon Asset Management
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies June 13 Oncology Investigator Call to Update Investors & Analysts on Phase 1 Sudocetaxel Zendusortide Trial
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
From Theratechnologies
Via GlobeNewswire
News headline image
Earnings Preview For Theratechnologies ↗
 
Via Benzinga
News headline image
Theratechnologies to Present Preliminary Safety and Efficacy Data from Phase 1 Trial of Sudocetaxel Zendusortide in Heavily Pretreated Cancer Patients at ASCO 2023
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Reports on its Annual Meeting of Shareholders
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies’ Trogarzo® (Ibalizumab-uiyk) Shortens Time to HIV Undetectability and Extends Durability of Undetectability and Viral Suppression in a Matched Treatment Comparison
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Data Presentations at AACR 2023 Showcase Potential of Sudocetaxel Zendusortide as a Single Agent and in Combination with other Anticancer Therapies
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Reports Financial Results and Business Updates for First Quarter 2023
From Theratechnologies
Via GlobeNewswire
News headline image
Earnings Scheduled For April 12, 2023 ↗
Companies Reporting Before The Bell • Theratechnologies (NASDAQ:THTX) is estimated to report quarterly loss at $0.05 per share on revenue of $21.76 million. 
Via Benzinga
News headline image
Theratechnologies to Announce First Quarter 2023 Financial Results and Provide Business Update
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Receives Nasdaq Notification Letter Regarding Share Price
From Theratechnologies
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  Tuesday's morning session saw 84 companies set new 52-week lows. 
Via Benzinga
News headline image
Theratechnologies Inc. (NASDAQ:THTX) Shareholder Notice: Investigation over Possible Breaches of Fiduciary Duties ↗
San Diego, CA -- (SBWIRE) -- 03/01/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Theratechnologies Inc. 
Via SBWire
News headline image
Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Announces Amendment to its Term Loan Facility With Affiliates of Marathon Asset Management
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome in People with HIV
From Theratechnologies
Via GlobeNewswire
News headline image
Earnings Scheduled For February 28, 2023 ↗
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. 
Via Benzinga
News headline image
Theratechnologies Announces Path to Resume TH1902 Clinical Development
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Inc. (NASDAQ:THTX) Investor Alert: Investigation over Possible Violations of Securities Laws ↗
San Diego, CA -- (SBWIRE) -- 01/17/2023 -- An investigation on behalf of investors of Theratechnologies Inc. (NASDAQ:THTX) shares over potential securities laws violations by Theratechnologies Inc. and... 
Via SBWire
News headline image
Open Letter to Shareholders from CEO Paul Levesque
Theratechnologies Announces Fiscal Year 2023 Guidance and Operating Plan’s Key Objectives 
From Theratechnologies
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  Tuesday's session saw 167 companies set new 52-week lows. 
Via Benzinga
News headline image
Dow Drops 100 Points; Asana Shares Plummet ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 100 points on Friday. 
Via Benzinga
News headline image
Why Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) rose 42% to $0.54 after dipping 56% on Thursday. 
Via Benzinga
News headline image
Gold Down 1%; Samsara Shares Spike Higher ↗
U.S. stocks traded lower midway through trading, with the Dow Jones falling around 75 points on Friday. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 72 companies hit new 52-week lows. 
Via Benzinga
News headline image
Dow Tumbles 300 Points After US Economy Adds 263,000 Jobs ↗
U.S. stocks traded lower this morning, with the Dow Jones falling more than 300 points on Friday following the release of jobs data for November. 
Via Benzinga
News headline image
Theratechnologies Announces Update from Ongoing TH1902 Study
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14,... 
From Theratechnologies
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.